I’m a PhD cancer biologist with an engineering (Princeton), medical (Stanford), and business (IESE) background. I spent a decade developing oncology drugs in big pharma. I've raised capital as a biotech CEO. I now work as an early-stage biotech venture builder focused on translating scientific innovation into investor-ready biotech companies. I work closely with founders at the earliest stages—helping shape ideas into clear, patient-focused, fundable opportunities. You'll hear me talk a lot about designing a strong development strategy and how to build a scientific and commercial narrative that resonates with investors and, later, pharma partners. My approach combines technical expertise with operator know-how and executive leadership to help make sure great science doesn’t get lost in translation. If you’re a scientist or founder looking to turn research into a company or prepare for early-stage fundraising, I’d love to connect on Hubble.